The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Light-enhanced and fear-potentiated startle: temporal characteristics and effects of α-helical corticotropin-releasing hormone
Abstract
Background It has been suggested that the light-enhanced startle paradigm (LES) is an animal model for anxiety, because of the unconditioned and nonspecific cue and the long-term effect. In contrast, the fear-potentiated startle (FPS) is suggested to model fear. In the present study, we assessed in detail the time course of LES and FPS and investigated whether corticotropin-releasing hormone (CRH) is differentially involved in these two models.Methods In experiment 1, the amplitude of the startle response was tracked in the presence of the light and after light offset, in both models. In experiment 2, the effects of intracerebroventricular administration of the CRH-receptor antagonist alpha-helical CRH (0, 1, 5, and 25 microg) on LES and FPS were studied.Results In LES, light onset resulted in a long-lasting potentiation of the startle response and a slow return to baseline after light offset. In FPS, the potentiation of the startle response returned to baseline almost immediately after light offset. Alpha-helical CRH reduced the potentiation in LES at the 5-microg dose but not at 25 microg. In FPS, alpha-helical CRH had no effect.Conclusions The results show that the time course of LES is markedly different from that of FPS, which together with the differences in eliciting stimuli suggest that they model anxiety and fear, respectively. Moreover, the results suggest that CRH is involved in LES and not in FPS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, sustained fear is measured using a more diffuse cue, or cues, arranged so that the subject does not know when during the aversive event will occur. This elicits a state of fear that can last for a much longer period of time and often decays more slowly after the fearful signal is removed (de Jongh et al, 2003).”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as de Jongh et al, 2003
In the citing paper
“In the laboratory, phasic fear can be measured using a short, discrete cue that is predictably paired with an aversive event. This elicits a state of fear highly time-locked to the fear-inducing stimulus that begins quickly and dissipates quickly once the fear stimulus is removed (Davis et al, 1989; de Jongh et al, 2003).”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as de Jongh et al, 2003
In the citing paper
“de Jongh et al (2003) reported that i.c.v. infusions of the CRF-R1/2 antagonist αhCRF9–41 had no effect on fear-potentiated startle to a 3.7-s light, but significantly disrupted light-enhanced startle at an intermediate (5 μg) but not at a higher dose (25 μg).”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as de Jongh et al, 2003
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Koch, M. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00098-7 · Cited by 1,287
Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences Clinical Psychiatry
Kaplan, H. I., Sadock, B. J., & Sadock, V. A. (1994) · Cited by 996
Fear-potentiated startle: A neural and pharmacological analysis
Davis, M., Falls, W. A., Campeau, S., & Kim, M. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90102-v · Cited by 748
Conditioned fear as revealed by magnitude of startle response to an auditory stimulus.
Brown, J. S., Kalish, H. I., & Farber, I. E. (1951) · Journal of Experimental Psychology · doi:10.1037/h0060166 · Cited by 637 · cited 1×
“Davis et al (1997) extended this work by showing that CRH-enhanced startle seems to be mediated by the BNST.”
BackgroundWalker, D. L., & Davis, M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09375.1997 · Cited by 627
A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
Koob, G. F., & Heinrichs, S. C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01991-5 · Cited by 531 · cited 1×
“On the other hand, CRH-receptor antagonists attenuate stress-induced freezing (Kalin et al 1988), reduce defensive burying (Korte et al 1994), reverse the stress-induced decrease of exploration on the open arms of the elevated-plus maze (Koob and Heinrichs 1999), and reduce conditioned freezing, both when administered…”
BackgroundKaplan and Sadock's synopsis of psychiatry
Sadock, B. J., & Sadock, V. A. (1998) · Cited by 450
Cited by
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
“This elicits a state of fear that can last for a much longer period of time and often decays more slowly after the fearful signal is removed (de Jongh et al, 2003).”
BackgroundInfluentialKorte, S. M., Koolhaas, J. M., Wingfield, J. C., & McEwen, B. S. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.08.009 · Cited by 1,097
Models and mechanisms of anxiety: evidence from startle studies
Grillon, C. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1019-1 · Cited by 456
“This anxiogenic reaction to lights is reflected by increased startle in lighted places compared to dark places (light-enhanced startle; de Jongh et al. 2003; Walker and Davis 1997b), an effect blocked by anxiogenic drugs (Walker and Davis 1997b, 2002a).”
BackgroundHuman Bed Nucleus of the Stria Terminalis Indexes Hypervigilant Threat Monitoring
Somerville, L. H., Whalen, P. J., & Kelley, W. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.002 · Cited by 351
Walker, D. L., Miles, L. A., & Davis, M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.022 · Cited by 331
“A Speculative Account of Unexpected Findings One of the more curious aspects of these data is the non-monotonic disruption of light-enhanced following oral administration of GSK876008 (Walker et al., 2008; and see also de Jongh et al., 2003 for similar effects of the CRF antagonist α-helical CRF).”
BackgroundInfluential
Metadata
- Authors
- de Jongh, R., Groenink, L., van der Gugten, J., & Olivier, B.
- Affiliations
- Utrecht University (NL)
- Yale University (US)
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 54
- Issue
- 10
- Pages
- 1041-1048
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2125491190
- Cited by
- 54
- References
- 40
- Citations by year
- 2026: 1 · 2023: 2 · 2020: 2 · 2018: 4 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- fear-potentiated startle, corticotropin-releasing factor, CRH receptor antagonist, anxiety models, intracerebroventricular administration
- MeSH terms
- Acoustic Stimulation, Animals, Anxiety, Behavior, Animal, Conditioning, Classical, Corticotropin-Releasing Hormone, Darkness, Disease Models, Animal, Dose-Response Relationship, Drug, Fear, Female, Hormone Antagonists, Injections, Intraventricular, Light, Male, Photic Stimulation, Reflex, Startle, Rats, Wistar, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Light-enhanced and fear-potentiated startle: temporal characteristics and effects of α-helical corticotropin-releasing hormone. https://app.cochat.ai/papers/10.1016/s0006-3223(03)00468-2
- The paper
- de Jongh, R., Groenink, L., van der Gugten, J., & Olivier, B. (2003). Light-enhanced and fear-potentiated startle: temporal characteristics and effects of α-helical corticotropin-releasing hormone. Biological Psychiatry. https://doi.org/10.1016/s0006-3223(03)00468-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.